Our TF family member analysis showed that RUNX1, RUNX2, and RUNX3 were all within the top 5 % of TFs correlated with hypomethylation of RUNX-containing enhancer probes in clear cell renal carcinoma (KIRC) (Fig. 7)a, b. The gene discussed is RUNX2; the disease is clear cell renal carcinoma.